IP Library › Granted Patent US 6,911,531
Granted Patent B2
US 6,911,531 · App. 10/108,714 · Granted Jun 28, 2005

Antibodies directed towards a novel human EP prostaglandin receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,911,531
App. No.
10/108,714
Granted
Jun 28, 2005
Kind
B2
Abstract

A gene encoding the HP4 human prostaglandin receptor is disclosed. The protein encoded by this gene exhibits significant sequence identity with other prostaglandin receptors. The HP4 receptor, when expressed in eukaryotic cells, is capable of binding prostaglandins and their analogs and stimulating adenylate cyclase activity in response to prostaglandins. Also disclosed are antisense agents able to decrease or prevent translation of a human HP4 prostaglandin receptor.

Claims (4)

1. A composition comprising an antibody able to specifically bind to a human prostaglandin HP4 receptor encoded by plasmid KS/HP4.

2. The composition of claim 1 , wherein said antibody is able to specifically bind to a polypeptide comprising a fragment of less than the entire human prostaglandin HP4 receptor, said fragment being unique as compared to a different human prostaglandin subtype.

3. The composition of claim 1 , wherein said composition is a polyclonal antibody preparation.

4. The composition of claim 1 , wherein said composition is a monoclonal antibody preparation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2003
From: ALLERGAN SALES, INC. (MERGED INTO ALLERGAN SALES, LLC 6/3/2002)
To: ALLERGAN, INC.
Reel/Frame 013898/0170 →